Outcomes and Prediction Models for Exclusive Prostate Bed Salvage Radiotherapy among Patients with Biochemical Recurrence after Radical Prostatectomy.
Chi-Shin TsengYu-Jen WangChung-Hsin ChenShuo-Meng WangKuo-How HuangPo-Ming ChowYeong-Shiau PuChao-Yuan HuangJason Chia-Hsien ChengPublished in: Cancers (2021)
In patients with a PSA < 0.45 ng/mL and PSA-DT > 8 months for post-prostatectomy BCR, prostate bed SRT provided excellent outcomes without the need for concomitant ADT or pelvic radiotherapy.